NEW CP103 Practical Tools for Improving Clinical Pathology Service

2:00–5:30 pm
3.0 CME CREDITS

This half-day course delivers the knowledge and skills to implement practical changes in your clinical laboratory, particularly if your primary duties are in anatomic pathology. Faculty will cover two key coagulation topics, chemistry/toxicology and microbiology, addressing how to make change as well as assess whether it makes sense given cost/benefit and other practical considerations. You will receive an annotated reference list that will allow you to learn more about changes to be considered for your clinical laboratory.

You will learn to:

Assess clinical considerations in heparin-induced thrombocytopenia antibody testing that drive laboratory testing
Recognize what constitutes an adequate assessment and validation of new PT and aPTT reagents when changing lots
Consult more effectively in urine drug screen testing
Determine what pharmacogenomic testing is sufficiently validated to warrant consideration for onsite or referral testing
Evaluate the appropriateness of rapid molecular identification of MRSA, Group B strep, enteroviruses, etc, in a community hospital laboratory
Discuss the future of bacterial and fungal sequencing technologies for a community pathologist

Faculty
Mark Fisher, PhD, D(ABMM)
John R. Harbour, MD, FCAP
Gwendolyn A. McMillin, PhD, DABCC
John D. Olson, MD, PhD, FCAP